Recommended Clear Fluid Intake Volume at 2 Hours Prior to Esophagogastroduodenoscopy for Adult Patients
1 other identifier
interventional
280
1 country
1
Brief Summary
Research in developing patient fasting guidelines was developed years ago. On a physiological basis, patients with a longer fasting time may have less residual gastric content and lower risk of pulmonary aspiration. The recent Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration of The American Society of Anesthesiologists (ASA) was published in March 2017. Current practice consists of 2-hour fasting period for clear oral fluid (including water, pulp-free juice and tea or coffee without milk), 4- hour fasting period for breast milk and 6-hour fasting period for non-human milk and solid food. However, there are only few supportive and suggestive scientific evidences. The purpose of this study is to evaluate the current clinical practice guidelines for preoperative fasting to enhance the quality of pediatric anesthesia care and promote patient safety.The investigators plan to enroll adults aged 18-60 years, who are scheduled for esophago-gastro-duodenoscopy (EGD), in order to study the effects of fasting time and the actual intragastric volume which may help us establish a comprehensive fasting guideline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 3, 2020
CompletedFirst Posted
Study publicly available on registry
August 6, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMarch 22, 2023
March 1, 2023
3.2 years
August 3, 2020
March 19, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Residual gastric volume
Collect actual intra-gastric content volume after drinking assigned amount of fluid at 2-hour fasting period of each patient.
at 2 hour after drinking, during endoscopic procedure
Secondary Outcomes (4)
Gastric acidity (pH)
at 2 hour after drinking, during endoscopic procedure
Hypotension
at 2 hour after drinking, during endoscopic procedure
Post operative nausea and vomitting
pre-endoscopic procedure
Ready to discharge time
When the procedure finish until ready to discharge, approximately 1-2 hours after endoscopy
Study Arms (4)
0 ml/kg
NO INTERVENTIONThe participants will not be asked to drink anything at 2 hours prior to planned procedure.
3 ml/kg
ACTIVE COMPARATORThe participants will be asked to drink 3ml/kg of clear liquid at 2 hours prior to planned procedure.
7 ml/kg
ACTIVE COMPARATORThe participants will be asked to drink 7 ml/kg of clear liquid at 2 hours prior to planned procedure.
10 ml/kg
ACTIVE COMPARATORThe participants will be asked to drink 10 ml/kg of clear liquid at 2 hours prior to planned procedure.
Interventions
Clear oral fluid including water, pulp-free juice and tea or coffee without milk
Eligibility Criteria
You may qualify if:
- Patients who are 18-60 years scheduled for EGD procedure
- Patient who willing to participate in this study
You may not qualify if:
- Patient who scheduled for emergent EGD procedures
- Patients with active upper GI bleeding
- Patients who received preoperative oral medication
- BMI \> 30 kg/m2
- Patients with previous GI motility or acid-base pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine, Siriraj hospital
Bangkok Noi, Bangkok, 10700, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2020
First Posted
August 6, 2020
Study Start
September 1, 2020
Primary Completion
December 1, 2023
Study Completion
December 1, 2024
Last Updated
March 22, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share